fenofibrate has been researched along with Injuries, Spinal Cord in 3 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fenofibrate treatment did not improve recovery, although there was a slight trend for a modest increase in histological tissue sparing." | 1.37 | The PPAR alpha agonist gemfibrozil is an ineffective treatment for spinal cord injured mice. ( Almad, A; Lash, AT; Lovett-Racke, AE; McTigue, DM; Wei, P, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Avraham, O | 1 |
| Feng, R | 1 |
| Ewan, EE | 1 |
| Rustenhoven, J | 1 |
| Zhao, G | 1 |
| Cavalli, V | 1 |
| La Fountaine, MF | 1 |
| Cirnigliaro, CM | 1 |
| Hobson, JC | 1 |
| Lombard, AT | 1 |
| Specht, AF | 1 |
| Dyson-Hudson, TA | 1 |
| Kirshblum, SC | 1 |
| Bauman, WA | 1 |
| Almad, A | 1 |
| Lash, AT | 1 |
| Wei, P | 1 |
| Lovett-Racke, AE | 1 |
| McTigue, DM | 1 |
1 trial available for fenofibrate and Injuries, Spinal Cord
| Article | Year |
|---|---|
A Four Month Randomized Controlled Trial on the Efficacy of Once-daily Fenofibrate Monotherapy in Persons with Spinal Cord Injury.
Topics: Adult; Cardiovascular Diseases; Female; Fenofibrate; Humans; Hypolipidemic Agents; Lipoproteins; Mal | 2019 |
2 other studies available for fenofibrate and Injuries, Spinal Cord
| Article | Year |
|---|---|
Profiling sensory neuron microenvironment after peripheral and central axon injury reveals key pathways for neural repair.
Topics: Animals; Axons; Biomarkers; Cell Proliferation; Cellular Microenvironment; Fenofibrate; Ganglia, Spi | 2021 |
The PPAR alpha agonist gemfibrozil is an ineffective treatment for spinal cord injured mice.
Topics: Animals; Dose-Response Relationship, Drug; Female; Fenofibrate; Gemfibrozil; Hypolipidemic Agents; M | 2011 |